Abivax receives clearance from U.S. FDA to initiate clinical trials with ABX464 to treat moderate to severe ulcerative colitis.
For more information, you can find our press release under the following link: https://abivax.gcs-web.com/news-releases/news-release-details/abivax-receives-clearance-us-fda-initiate-clinical-trials-abx464
LifeSci Capital Alpha Series:Adam Evertts & David Sherman
Bryan, Garnier & Co:Eric Le Berrigaud & Jean-Jacques Le Fur
- Contact Eric Le Berrigaud
- Contact Jean-Jacques Le Fur
- Bryan, Garnier & Co analyst report executive summary